勃起功能障碍:冠状动脉疾病的 “前哨信号”
Erectile Dysfunction: A “Sentinel Signal” for Coronary Artery Disease
DOI: 10.12677/acm.2026.1662340, PDF,   
作者: 徐 昊:西安医学院第一附属医院全科医学院,陕西 西安;严琴琴*:西安医学院临床医学院,陕西 西安
关键词: 勃起功能障碍冠状动脉疾病心血管风险预警信号Erectile Dysfunction Coronary Artery Disease Cardiovascular Risk Warning Sign
摘要: 勃起功能障碍(ED)与冠状动脉疾病(CAD)同源,均为血管内皮功能障碍与动脉粥样硬化在不同靶器官的表现。动脉尺寸假说认为,阴茎动脉更细,病变更早,故ED常较CAD症状提前2~5年出现,是心血管事件的独立预警信号。流行病学显示,两者互为高风险因素:CAD患者ED高发,ED患者主要不良心血管事件风险显著上升。临床应推行“心–性同治”,将ED纳入心血管风险评估,实现早期预警与协同防治。
Abstract: Erectile Dysfunction (ED) and Coronary Artery Disease (CAD) share a common origin, both representing vascular endothelial dysfunction and atherosclerosis manifesting in different target organs. The penile artery size hypothesis posits that the smaller diameter of the penile artery predisposes it to earlier pathological changes, which explains why ED typically precedes CAD symptoms by 2~5 years, serving as an independent sentinel marker of cardiovascular events. Epidemiological evidence confirms a bidirectional relationship: CAD patients have a high prevalence of ED, and men with ED face a significantly elevated risk of major adverse cardiovascular events. In clinical practice, a “cardio-sexual” management approach should be adopted, integrating ED assessment into cardiovascular risk evaluation to enable early warning and collaborative prevention.
文章引用:徐昊, 严琴琴. 勃起功能障碍:冠状动脉疾病的 “前哨信号”[J]. 临床医学进展, 2026, 16(6): 1301-1306. https://doi.org/10.12677/acm.2026.1662340

参考文献

[1] Virani, S.S., Newby, L.K., Arnold, S.V., Bittner, V., Brewer, L.C., et al. (2023) 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients with Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 148, e9-e119. [Google Scholar] [CrossRef] [PubMed]
[2] 勃起功能障碍诊断与治疗指南[J]. 中华男科学杂志, 2022, 28(8): 722-755.
[3] Xiong, Y., Zhang, F., Zhang, Y., Wang, W., Ran, Y., Wu, C., et al. (2024) Insights into Modifiable Risk Factors of Erectile Dysfunction, a Wide-Angled Mendelian Randomization Study. Journal of Advanced Research, 58, 149-161. [Google Scholar] [CrossRef] [PubMed]
[4] Gandaglia, G., Briganti, A., Jackson, G., Kloner, R.A., Montorsi, F., Montorsi, P., et al. (2014) A Systematic Review of the Association between Erectile Dysfunction and Cardiovascular Disease. European Urology, 65, 968-978. [Google Scholar] [CrossRef] [PubMed]
[5] Madani, A.H., Mirbolouk, F., Naghshbandi, M., et al. (2025) Associated Factors for Erectile Dysfunction Occurrence in Patients with Coronary Artery Disease: A Cross-Sectional Study. Iranian Journal of Medical Sciences, 50, 37-43.
[6] Desai, M., Naik, G., Kamat, U.S. and Cacodcar, J.A. (2020) Concurrence of Erectile Dysfunction and Coronary Artery Disease among Patients Undergoing Coronary Angiography at a Tertiary Medical College Hospital in Goa. Indian Heart Journal, 72, 123-125. [Google Scholar] [CrossRef] [PubMed]
[7] Köhler, T.S., Kloner, R.A., Rosen, R.C., Burnett, A.L., Blaha, M.J., Ganz, P., et al. (2024) The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clinic Proceedings, 99, 1500-1517. [Google Scholar] [CrossRef] [PubMed]
[8] Miner, M., Parish, S.J., Billups, K.L., Paulos, M., Sigman, M. and Blaha, M.J. (2019) Erectile Dysfunction and Subclinical Cardiovascular Disease. Sexual Medicine Reviews, 7, 455-463. [Google Scholar] [CrossRef] [PubMed]
[9] Priviero, F., Hollis, F., Wood, S.K., Uline, M., Andersson, K. and Webb, R.C. (2026) Erectile and Clitoral Dysfunction as Harbingers of Cardiovascular Disease: A Perspective. Medicina, 62, Article 416. [Google Scholar] [CrossRef
[10] 徐科伟, 华茂红, 杨新. 阴茎勃起功能障碍对冠状动脉疾病的早期预测作用[J]. 浙江临床医学, 2017, 19(1): 66-67.
[11] 李淑萍, 王沛涛, 蔺静, 等. 冠心病与勃起功能障碍相关性的研究[J]. 中外医疗, 2021, 40(19): 49-51.
[12] Bhattacharya, R., Marnell, C.S., Cho, S.M.J., Patel, A.P., Ruan, Y., Koyama, S., et al. (2025) Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident Cad. Circulation: Genomic and Precision Medicine, 18, e004937. [Google Scholar] [CrossRef] [PubMed]
[13] Montorsi, P., Ravagnani, P. and Vlachopoulos, C. (2015) Clinical Significance of Erectile Dysfunction Developing after Acute Coronary Event: Exception to the Rule or Confirmation of the Artery Size Hypothesis? Asian Journal of Andrology, 17, 21-25. [Google Scholar] [CrossRef] [PubMed]
[14] 中国中医药研究促进会, 中国民族医药学会整合医学分会, 陶丽丽, 等. 中成药防治泛血管疾病及其靶器官损害的专家共识[J]. 中国全科医学, 2026, 29(9): 1089-1108.
[15] Montorsi, P., Ravagnani, P.M., Galli, S., Rotatori, F., Briganti, A., Salonia, A., et al. (2005) The Artery Size Hypothesis: A Macrovascular Link between Erectile Dysfunction and Coronary Artery Disease. The American Journal of Cardiology, 96, 19-23. [Google Scholar] [CrossRef] [PubMed]
[16] Villalba, N., Martínez, P., Bríones, A.M., Sánchez, A., Salaíces, M., García-Sacristán, A., et al. (2009) Differential Structural and Functional Changes in Penile and Coronary Arteries from Obese Zucker Rats. American Journal of Physiology-Heart and Circulatory Physiology, 297, H696-H707. [Google Scholar] [CrossRef] [PubMed]
[17] Segura, A., Muriel, J., Miró, P., Agulló, L., Arrarte, V., Carracedo, P., et al. (2024) Erectile Dysfunction in Cardiovascular Patients: A Prospective Study of the eNOS Gene T‐786C, G894T, and INTRON Variable Number of the Tandem Repeat Functional Interaction. Andrology, 13, 794-803. [Google Scholar] [CrossRef] [PubMed]
[18] Nehra, A., Jackson, G., Miner, M., Billups, K.L., Burnett, A.L., Buvat, J., et al. (2012) The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clinic Proceedings, 87, 766-778. [Google Scholar] [CrossRef] [PubMed]
[19] Burnett, A.L., Nehra, A., Breau, R.H., Culkin, D.J., Faraday, M.M., Hakim, L.S., et al. (2018) Erectile Dysfunction: AUA Guideline. Journal of Urology, 200, 633-641. [Google Scholar] [CrossRef] [PubMed]
[20] 杨四文, 孙菊元, 田维云, 等. 国际勃起功能评分5联合夜间阴茎勃起监测在阴茎勃起功能障碍患者诊断中的应用研究[J]. 中华临床医师杂志(电子版), 2012, 6(17): 5266-5267.
[21] Ghanem, H. and Shamloul, R. (2008) An Evidence-Based Perspective to Commonly Performed Erectile Dysfunction Investigations. The Journal of Sexual Medicine, 5, 1582-1589. [Google Scholar] [CrossRef] [PubMed]
[22] Salonia, A., Capogrosso, P., Boeri, L., Cocci, A., Corona, G., Dinkelman-Smit, M., et al. (2025) European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie’s Disease. European Urology, 88, 76-102. [Google Scholar] [CrossRef] [PubMed]
[23] Czyzewski, B., Czyzewska, J., Dorota, A., Dorota, M., Kozlowski, K., Zywiec, W., et al. (2025) The Impact of Commonly Used Medications on Erectile Dysfunction: Which Drugs Deserve Particular Attention? Cureus, 17, e93259. [Google Scholar] [CrossRef
[24] Thomas, C. and Konstantinidis, C. (2021) Neurogenic Erectile Dysfunction. Where Do We Stand? Medicines, 8, Article 3. [Google Scholar] [CrossRef] [PubMed]
[25] Althof, S.E. and Rosen, R.C. (2025) Psychological Perspectives on Male Erectile Dysfunction: A Reappraisal. Sexual Medicine Reviews, 14, qeaf052. [Google Scholar] [CrossRef